Flunarizine

This classification denotes a histamine-1 receptor antagonist and calcium channel blocker with the molecular formula C26H26F2N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R7PLA2DM0J, chemically known as piperazine, 1-(bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)-, (e)- but generally known as flunarizine, which bears US NIH Compound Identifier 941361. European Medicines Agency schedules Flunarizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07707MIG. The term FLUNARIZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules flunarizine in its Anatomical Therapeutic Chemical (ATC) Classification. FLUNARIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flunarizine under HS 29335995 and SITC 51576. As of Q4 2014, FLUNARIZINE remains the US FDA Preferred Term for this commodity. Flunarizine bears US NLM identifiers UMLS ID C0016295 and NCI Concept Code C83718. SMILES: FC1CCC(C(N2CCN(CC2)C/C=C/C2CCCCC2)C2CCC(F)CC2)CC1.